| 000 | 01719 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514053353.0 | ||
| 264 | 0 | _c20021224 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(02)11680-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhan, Wasif A | |
| 245 | 0 | 0 |
_aComparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 2002 |
||
| 300 |
_a1722-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAzithromycin _xadministration & dosage |
| 650 | 0 | 4 | _aBangladesh |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCholera _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aErythromycin _xadministration & dosage |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVibrio cholerae O1 _xisolation & purification |
| 650 | 0 | 4 |
_aVibrio cholerae O139 _xisolation & purification |
| 700 | 1 | _aSaha, Debasish | |
| 700 | 1 | _aRahman, Anisur | |
| 700 | 1 | _aSalam, Mohammed A | |
| 700 | 1 | _aBogaerts, Joseph | |
| 700 | 1 | _aBennish, Michael L | |
| 773 | 0 |
_tLancet (London, England) _gvol. 360 _gno. 9347 _gp. 1722-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(02)11680-1 _zAvailable from publisher's website |
| 999 |
_c12285030 _d12285030 |
||